BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38751042)

  • 21. Molecular cloning and characterization of rhesus monkey platelet glycoprotein Ibα, a major ligand-binding subunit of GPIb-IX-V complex.
    Qiao J; Shen Y; Shi M; Lu Y; Cheng J; Chen Y
    Thromb Res; 2014 May; 133(5):817-25. PubMed ID: 24560895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction.
    Jose RA; Voet A; Broos K; Jakobi AJ; Bruylants G; Egle B; Zhang KY; De Maeyer M; Deckmyn H; De Borggraeve WM
    Chem Commun (Camb); 2012 Nov; 48(92):11349-51. PubMed ID: 23072895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
    Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
    Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
    Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis.
    Li S; Wang Z; Liao Y; Zhang W; Shi Q; Yan R; Ruan C; Dai K
    J Thromb Haemost; 2010 Feb; 8(2):341-50. PubMed ID: 19840363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
    Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
    J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation.
    Dayananda KM; Singh I; Mondal N; Neelamegham S
    Blood; 2010 Nov; 116(19):3990-8. PubMed ID: 20696943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Pro1266Leu mutation on structure and function of glycoprotein Ib binding domain of von Willebrand factor.
    Naqvi AAT; Alajmi MF; Rehman T; Hussain A; Hassan I
    J Cell Biochem; 2019 Oct; 120(10):17847-17857. PubMed ID: 31135071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of glycoprotein Ibalpha mobility in platelet function.
    van der Wal DE; Verhoef S; Schutgens RE; Peters M; Wu Y; Akkerman JW
    Thromb Haemost; 2010 May; 103(5):1033-43. PubMed ID: 20216992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide.
    David T; Ohlmann P; Eckly A; Moog S; Cazenave JP; Gachet C; Lanza F
    J Thromb Haemost; 2006 Dec; 4(12):2645-55. PubMed ID: 17100656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of VWF-mediated platelet GPIbalpha binding.
    Auton M; Zhu C; Cruz MA
    Biophys J; 2010 Aug; 99(4):1192-201. PubMed ID: 20713003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow-induced elongation of von Willebrand factor precedes tension-dependent activation.
    Fu H; Jiang Y; Yang D; Scheiflinger F; Wong WP; Springer TA
    Nat Commun; 2017 Aug; 8(1):324. PubMed ID: 28831047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib.
    Blenner MA; Dong X; Springer TA
    J Biol Chem; 2014 Feb; 289(9):5565-79. PubMed ID: 24391089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
    Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
    Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
    Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
    Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular dynamics simulation of force-regulated interaction between glycoprotein Ib
    Tao R; Xie X; Wu J; Fang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Oct; 40(5):876-885. PubMed ID: 37879916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional association of phosphoinositide-3-kinase with platelet glycoprotein Ibalpha, the major ligand-binding subunit of the glycoprotein Ib-IX-V complex.
    Mu FT; Cranmer SL; Andrews RK; Berndt MC
    J Thromb Haemost; 2010 Feb; 8(2):324-30. PubMed ID: 19874472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.